Taiwan Shenlong

ScinoPharm Taiwan is a leading global contract development and manufacturing organization (CDMO) specializing in high-quality active pharmaceutical ingredients (APIs). Founded in 1997 and headquartered in Tainan, Taiwan, the company provides a full range of services from process development to commercial-scale production. ScinoPharm is particularly renowned for its expertise in highly potent APIs (HPAPI), especially for oncology applications, and has expanded into injectable drug product manufacturing. The company serves major pharmaceutical and biotech firms worldwide, maintaining facilities that comply with international GMP standards. Its strategic focus includes the development of complex generic APIs and providing outsourcing services for innovative drug candidates.